Prompt relapse of viremia after lamivudine discontinuation in e-minus chronic hepatitis B (e-CHB) patients completely responders during 5 years of therapy
- 30 September 2004
- journal article
- other
- Published by Elsevier in Journal of Hepatology
- Vol. 41 (3) , 500-501
- https://doi.org/10.1016/j.jhep.2004.04.018
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Current management of chronic hepatitis BAlimentary Pharmacology & Therapeutics, 2003
- Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis BGut, 2002
- Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine TherapyHepatology, 2000
- Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudineJournal of Hepatology, 2000
- Efficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis BbHepatology, 1999